WEC
NDRA icon

Winslow Evans & Crocker’s ENDRA Life Sciences NDRA Stock Holding History

Winslow Evans & Crocker’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed -$34K – 1155
2019
Q4 		$34K Hold
1
– – 0.01% 573
2019
Q3 		$22K Hold
1
– – 0.01% 635
2019
Q2 		$36K Hold
1
– – 0.01% 577
2019
Q1 		$34K Hold
1
– – 0.01% 574
2018
Q4 		$30K Hold
1
– – 0.01% 555
2018
Q3 		$62K Hold
1
– – 0.02% 448
2018
Q2 		$52K Hold
1
– – 0.02% 485
2018
Q1 		$52K Hold
1
– – 0.02% 473
2017
Q4 		$97.2K Buy
+1
New +$113K 0.03% 373

Other funds holding NDRA

IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winslow Evans & Crocker's NDRA Position: Q1 2020 in Review

Winslow Evans & Crocker sold out of ENDRA Life Sciences (NDRA) in Q1 2020, closing a stake of 1 share — an estimated $34K sold.

Winslow Evans & Crocker first reported a position in NDRA in Q4 2017 and held it in 9 quarters. The position peaked at $97.2K in Q4 2017. 5 funds tracked by Wall St. Rank hold NDRA as of Q1 2020.

  • Winslow Evans & Crocker reported no remaining ENDRA Life Sciences position as of Q1 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1 ENDRA Life Sciences share in Q1 2020, an estimated $34K.
  • Winslow Evans & Crocker first reported a position in ENDRA Life Sciences in Q4 2017 and held it in 9 quarters.
  • Winslow Evans & Crocker's ENDRA Life Sciences position peaked at $97.2K in Q4 2017.
  • 5 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2020.

Based on Winslow Evans & Crocker's 13F filing for Q1 2020, filed 20 Apr 2020.